Colchicine Semisynthetics: Chemotherapeutics for Cancer?

Author(s): G. Sivakumar

Journal Name: Current Medicinal Chemistry

Volume 20 , Issue 7 , 2013


Become EABM
Become Reviewer
Call for Editor

Abstract:

Nitrogen-containing bioactive alkaloids of plant origin play a significant role in human health and medicine. Several semisynthetic antimitotic alkaloids are successful in anticancer drug development. Gloriosa superba biosynthesizes substantial quantities of colchicine, a bioactive molecule for gout treatment. Colchicine also has antimitotic activity, preventing growth of cancer cells by interacting with microtubules, which could lead to the design of better cancer therapeutics. Further, several colchicine semisynthetics are less toxic than colchicine. Research is being conducted on effective, less toxic colchicine semisynthetic formulations with potential drug delivery strategies directly targeting multiple solid cancers. This article reviews the dynamic state of anticancer drug development from colchicine semisynthetics and natural colchicine production and briefly discusses colchicine biosynthesis.

Keywords: Bioreactor, cancer, colchicine, thiocolchicine dimers, Gloriosa superba, Colchicine Semisynthetics, Chemotherapeutics, bioactive alkaloids, plant origin, antimitotic alkaloids

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 7
Year: 2013
Published on: 10 February, 2013
Page: [892 - 898]
Pages: 7
DOI: 10.2174/0929867311320070005
Price: $65

Article Metrics

PDF: 18